A citation-based method for searching scientific literature

Y H Gong, A S Parsadanian, A Andreeva, W D Snider, J L Elliott. J Neurosci 2000
Times Cited: 256



Lindsey R Fischer, Deborah G Culver, Philip Tennant, Albert A Davis, Minsheng Wang, Amilcar Castellano-Sanchez, Jaffar Khan, Meraida A Polak, Jonathan D Glass. Exp Neurol 2004
Times Cited: 951




List of shared articles



Times cited

The Skeletal Muscle Emerges as a New Disease Target in Amyotrophic Lateral Sclerosis.
Oihane Pikatza-Menoio, Amaia Elicegui, Xabier Bengoetxea, Neia Naldaiz-Gastesi, Adolfo López de Munain, Gorka Gerenu, Francisco Javier Gil-Bea, Sonia Alonso-Martín. J Pers Med 2021
9


Glial Cells-The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment.
Tereza Filipi, Zuzana Hermanova, Jana Tureckova, Ondrej Vanatko, And Miroslava Anderova. J Clin Med 2020
33



Targeting Macrophage for the Treatment of Amyotrophic Lateral Sclerosis.
Lian Li, Jie Liu, Hua She. CNS Neurol Disord Drug Targets 2019
2

The Genetic Diagnosis of Neurodegenerative Diseases and Therapeutic Perspectives.
Julio-César García, Rosa-Helena Bustos. Brain Sci 2018
15

Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis.
Valentina Cappello, Maura Francolini. Int J Mol Sci 2017
50

From animal models to human disease: a genetic approach for personalized medicine in ALS.
Vincent Picher-Martel, Paul N Valdmanis, Peter V Gould, Jean-Pierre Julien, Nicolas Dupré. Acta Neuropathol Commun 2016
86

Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis.
Kristopher G Hooten, David R Beers, Weihua Zhao, Stanley H Appel. Neurotherapeutics 2015
171


Rodent Models of Amyotrophic Lateral Sclerosis.
Thomas Philips, Jeffrey D Rothstein. Curr Protoc Pharmacol 2015
152

Advances in cellular models to explore the pathophysiology of amyotrophic lateral sclerosis.
C Veyrat-Durebex, P Corcia, A Dangoumau, F Laumonnier, E Piver, P H Gordon, C R Andres, P Vourc'h, H Blasco. Mol Neurobiol 2014
14

Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS).
Lindsay Poppe, Laura Rué, Wim Robberecht, Ludo Van Den Bosch. Exp Neurol 2014
40


Viral delivery of antioxidant genes as a therapeutic strategy in experimental models of amyotrophic lateral sclerosis.
Aikaterini Nanou, Adrian Higginbottom, Chiara F Valori, Matthew Wyles, Ke Ning, Pamela Shaw, Mimoun Azzouz. Mol Ther 2013
30

Quantity and activation of myofiber-associated satellite cells in a mouse model of amyotrophic lateral sclerosis.
Raquel Manzano, Janne M Toivonen, Ana Cristina Calvo, Sara Oliván, Pilar Zaragoza, Maria Jesús Muñoz, Didier Montarras, Rosario Osta. Stem Cell Rev Rep 2012
11

The complex molecular biology of amyotrophic lateral sclerosis (ALS).
Rachel L Redler, Nikolay V Dokholyan. Prog Mol Biol Transl Sci 2012
105

The Role of the Innate Immune System in ALS.
Sudarshan Phani, Diane Berengere Re, Serge Przedborski. Front Pharmacol 2012
35

Motor neuron trophic factors: therapeutic use in ALS?
Thomas W Gould, Ronald W Oppenheim. Brain Res Rev 2011
48


Complement upregulation and activation on motor neurons and neuromuscular junction in the SOD1 G93A mouse model of familial amyotrophic lateral sclerosis.
Bianca Heurich, Nawal Bahia El Idrissi, Rossen M Donev, Susanne Petri, Peter Claus, James Neal, B Paul Morgan, Valeria Ramaglia. J Neuroimmunol 2011
43

Granulocyte colony stimulating factor attenuates inflammation in a mouse model of amyotrophic lateral sclerosis.
Eveliina Pollari, Ekaterina Savchenko, Merja Jaronen, Katja Kanninen, Tarja Malm, Sara Wojciechowski, Toni Ahtoniemi, Gundars Goldsteins, Raisa Giniatullina, Rashid Giniatullin,[...]. J Neuroinflammation 2011
50

Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis.
Laura Ferraiuolo, Janine Kirby, Andrew J Grierson, Michael Sendtner, Pamela J Shaw. Nat Rev Neurol 2011
412

Inflammation in ALS and SMA: sorting out the good from the evil.
Dimitra Papadimitriou, Virginia Le Verche, Arnaud Jacquier, Burcin Ikiz, Serge Przedborski, Diane B Re. Neurobiol Dis 2010
101



Nerve terminal degeneration is independent of muscle fiber genotype in SOD1 mice.
Dario I Carrasco, Edyta K Bichler, Kevin L Seburn, Martin J Pinter. PLoS One 2010
14